Live feed
Filing
SC 13D/A
SC 13D/A0000947871-19-000210·ORBIMED ADVISORS LLC
Schedule 13D ownership disclosure
X4 PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98420X103
Event date: 2019-03-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 311,493
- Percent of class
- 4.6500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-19-000210
- Form type
- SC 13D/A
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Mar 19, 2019
- Reporting period
- Mar 13, 2019
- Description
- Schedule 13D beneficial ownership